Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyuan Shen

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nature Biomedical Engineering|March 18, 2026
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapyYan-Ruide Li, Haochen Nan, Zeyang Liu, et al.
Journal of Hematology & Oncology|October 12, 2025
Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activityYan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.
Research Square|April 29, 2025
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapySong Li, Yan-Ruide Li, Haochen Nan, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 1, 2023
Inhibition of Tumor Metastasis by Liquid-Nitrogen-Shocked Tumor Cells with Oncolytic Viruses InfectionQing Wu, Hanwei Huang, Mengchi Sun, et al.
Research (Washington, D.C.)|June 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural MesotheliomaYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safetyYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Signal Transduction and Targeted Therapy|March 14, 2026
Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumorsYan-Ruide Li, Miao Li, Yuning Chen, et al.
Nature Communications|September 27, 2024
Structural basis of ligand recognition and activation of the histamine receptor familyXuan Zhang, Guibing Liu, Ya-Ni Zhong, et al.
Signal Transduction and Targeted Therapy|November 21, 2024
Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumorsChaojie Zhu, Chao Liu, Qing Wu, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2024
Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer TreatmentZhengjie Zhao, Yinxian Yang, Tao Sheng, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nature Biomedical Engineering|March 18, 2026
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapyYan-Ruide Li, Haochen Nan, Zeyang Liu, et al.
Journal of Hematology & Oncology|October 12, 2025
Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activityYan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.
Research Square|April 29, 2025
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapySong Li, Yan-Ruide Li, Haochen Nan, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 1, 2023
Inhibition of Tumor Metastasis by Liquid-Nitrogen-Shocked Tumor Cells with Oncolytic Viruses InfectionQing Wu, Hanwei Huang, Mengchi Sun, et al.
Research (Washington, D.C.)|June 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural MesotheliomaYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safetyYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Signal Transduction and Targeted Therapy|March 14, 2026
Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumorsYan-Ruide Li, Miao Li, Yuning Chen, et al.
Nature Communications|September 27, 2024
Structural basis of ligand recognition and activation of the histamine receptor familyXuan Zhang, Guibing Liu, Ya-Ni Zhong, et al.
Signal Transduction and Targeted Therapy|November 21, 2024
Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumorsChaojie Zhu, Chao Liu, Qing Wu, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2024
Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer TreatmentZhengjie Zhao, Yinxian Yang, Tao Sheng, et al.
Pageof 5